Considerations for simultaneous testing of COVID-19 and tuberculosis in high-burden countries.

Ruhwald, Morten; Hannay, Emma; Sarin, Sanjay; Kao, Kekeletso; Sen, Rajashree; Chadha, Sarabjit

Ruhwald, Morten; Hannay, Emma; Sarin, Sanjay; Kao, Kekeletso; Sen, Rajashree; Chadha, Sarabjit.

Afiliação

Ruhwald M; FIND, Campus Biotech, Geneva 1202, Switzerland. Electronic address: morten.ruhwald@finddx.org.
Hannay E; FIND, Campus Biotech, Geneva 1202, Switzerland.
Sarin S; FIND, Campus Biotech, Geneva 1202, Switzerland.
Kao K; FIND, Campus Biotech, Geneva 1202, Switzerland.
Sen R; FIND, New Delhi, India.
Chadha S; FIND, New Delhi, India.

Lancet Glob Health ; 10(4): e465-e466, 2022 04.

Article em En | MEDLINE | ID: mdl-35122718

Assuntos

COVID-19; Tuberculose; Humanos; SARS-CoV-2; Tuberculose/diagnóstico; Tuberculose/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Lancet Glob Health Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google